A Comparative Study Between Combined and Separate EUS and ERCP under Anesthesia for Pancreaticobiliary Diseases

黄平,张筱凤,张啸,吕文,郭英辉,林秀英,袁庆丰,范震,王霞
DOI: https://doi.org/10.3760/cma.j.issn.1007-5232.2013.12.005
2013-01-01
Abstract:Objective To explore the therapeutic value of endoscopic ultrasonography (EUS) combined with endoscopic retrograde cholangiopancreatography (ERCP) for the diagnosis and treatment of pancreaticobiliary diseases.Methods Clinical data were analysed retrospectively in patients who underwent both EUS and ERCP in a single anesthetic session (Group A) and separate procedure in two different sessions (Group B).The following variables of both groups were evaluated:procedural time,propofol dose,cardiopulmonary complications,endoscopic complications and diagnostic yield,and therapeutic procedures.Results Proceduraltime [GroupAvs.GroupB:(78.56 ±-15.88) min vs.(97.78±34.56)min] andthe dose of propofol [Group A vs.Group B:(314.21 ±223.54)mg vs.(521.23 ±245.12)mg] differed significantly between both groups (P < 0.05).In Group A,the diagnostic rates of EUS and ERCP,cardiopulmonary complications rate and endoscopic complications rate were 91.4% (96/105),81.9% (86/105),6.67% (7/105),3.81% (4/105),respectively,and these variables of group B were 94.4% (85/90),82.2% (74/90),5.56% (5/90),3.33% (3/90).There were no significant differences in the diagnostic yield,cardiopulmonary complications and endoscopic complications between the two groups (P > 0.05).Conclusion It is safe and feasible that EUS combined with ERCP is performed under anesthesia in a single session.It needs a significantly shorter procedural time and smaller dose of propofol compared with separate procedures for pancreaticobiliary diseases.
What problem does this paper attempt to address?